Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation

被引:0
作者
Gruver, EJ
Fatkin, D
Dodds, GA
Kisslo, J
Maron, BJ
Seidman, JG
Seidman, CE
机构
[1] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[2] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA
[3] Howard Hughes Med Inst, Boston, MA 02115 USA
[4] Duke Univ, Dept Cardiol, Durham, NC USA
[5] Minneapolis Heart Inst Fdn, Minneapolis, MN USA
[6] Brigham & Womens Hosp, Dept Cardiol, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
More than 40 different beta-cardiac myosin heavy chain (beta-MHC) missense mutations have been identified that cause familial hypertrophic cardiomyopathy (FHC). Some of these are recognized to have important clinical manifestations, such as an increased incidence of sudden death. We report that the beta-MHC missense mutation Arg663His causes predominant cardiac morphology and atrial fibrillation. Longitudinal clinical evaluations were performed in a kindred with FHC. The nucleotide sequence of the beta-MHC gene was analyzed to define the causal mutation. A missense mutation in the beta-MHC gene, Arg663His, was identified in 24 individuals. Clinical studies demonstrated modest left ventricular hypertrophy in affected individuals, predominantly localized in the proximal segment of the interventricular septum, which increased (average = 40 +/- 8%) during 7 years of follow-up. Results showed that 47% of Arg663His adults (age >16 years) with ventricular hypertrophy developed atrial fibrillation, significantly more (p <0.001) than observed in ungenotyped FHC populations. Survival of affected individuals remained near normal. The beta-MHC missense mutation Arg663His causes a characteristic pattern of ventricular hypertrophy, Arg663His individuals have a markedly higher prevalence of atrial fibrillation, compared with a population with ungenotyped hypertrophic cardiomyopathy. The demonstration of phenotype as a direct consequence of genotype further extends the utility of molecular data in clinical medicine. Early identification of Arg663His individuals has the potential to minimize the serious sequelae of this arrhythmia in this FHC group. (C) 1999 by Excerpta Medico, Inc.
引用
收藏
页码:13H / 18H
页数:6
相关论文
共 24 条
  • [1] CARDIAC MYOSIN BINDING PROTEIN-C GENE SPLICE ACCEPTOR SITE MUTATION IS ASSOCIATED WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    BONNE, G
    CARRIER, L
    BERCOVICI, J
    CRUAUD, C
    RICHARD, P
    HAINQUE, B
    GAUTEL, M
    LABEIT, S
    JAMES, M
    BECKMANN, J
    WEISSENBACH, J
    VOSBERG, HP
    FISZMAN, M
    KOMAJDA, M
    SCHWARTZ, K
    [J]. NATURE GENETICS, 1995, 11 (04) : 438 - 440
  • [2] Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration
    Cecchi, F
    Montereggi, A
    Olivotto, I
    Marconi, P
    Dolara, A
    Maron, BJ
    [J]. HEART, 1997, 78 (01) : 44 - 49
  • [3] HETEROGENEOUS MORPHOLOGIC EXPRESSION OF GENETICALLY TRANSMITTED HYPERTROPHIC CARDIOMYOPATHY - TWO-DIMENSIONAL ECHOCARDIOGRAPHIC ANALYSIS
    CIRO, E
    NICHOLS, PF
    MARON, BJ
    [J]. CIRCULATION, 1983, 67 (06) : 1227 - 1233
  • [4] PREVALENCE OF ATRIAL-FIBRILLATION IN ELDERLY SUBJECTS (THE CARDIOVASCULAR HEALTH STUDY)
    FURBERG, CD
    PSATY, BM
    MANOLIO, TA
    GARDIN, JM
    SMITH, VE
    RAUTAHARJU, PM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (03) : 236 - 241
  • [5] A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION
    GEISTERFERLOWRANCE, AAT
    KASS, S
    TANIGAWA, G
    VOSBERG, HP
    MCKENNA, W
    SEIDMAN, CE
    SEIDMAN, JG
    [J]. CELL, 1990, 62 (05) : 999 - 1006
  • [6] IDENTIFICATION OF MUTATIONS LEADING TO THE LESCH-NYHAN SYNDROME BY AUTOMATED DIRECT DNA SEQUENCING OF INVITRO AMPLIFIED CDNA
    GIBBS, RA
    NGUYEN, PN
    MCBRIDE, LJ
    KOEPF, SM
    CASKEY, CT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (06) : 1919 - 1923
  • [7] Holmes KC, 1998, CIBA F SYMP, V213, P76
  • [8] THE COMPLETE SEQUENCE OF THE HUMAN BETA-MYOSIN HEAVY-CHAIN GENE AND A COMPARATIVE-ANALYSIS OF ITS PRODUCT
    JAENICKE, T
    DIEDERICH, KW
    HAAS, W
    SCHLEICH, J
    LICHTER, P
    PFORDT, M
    BACH, A
    VOSBERG, HP
    [J]. GENOMICS, 1990, 8 (02) : 194 - 206
  • [9] MAPPING A GENE FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY TO CHROMOSOME-14Q1
    JARCHO, JA
    MCKENNA, W
    PARE, JAP
    SOLOMON, SD
    HOLCOMBE, RF
    DICKIE, S
    LEVI, T
    DONISKELLER, H
    SEIDMAN, JG
    SEIDMAN, CE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (20) : 1372 - 1378
  • [10] Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
    Kimura, A
    Harada, H
    Park, JE
    Nishi, H
    Satoh, M
    Takahashi, M
    Hiroi, S
    Sasaoka, T
    Ohbuchi, N
    Nakamura, T
    Koyanagi, T
    Hwang, TH
    Choo, TA
    Chung, KS
    Hasegawa, A
    Nagai, R
    Okazaki, O
    Nakamura, H
    Matsuzaki, M
    Sakamoto, T
    Toshima, H
    Koga, Y
    Imaizumi, T
    Sasazuki, T
    [J]. NATURE GENETICS, 1997, 16 (04) : 379 - 382